contact us | home
 

PuriCore Investor Relations

PuriCore Investment Thesis

  • There is a critical need for safe, effective, natural solutions to control the spread of infectious pathogens.
  • Our technology is scientifically proven and intellectually protected.
  • We already have significant share and leadership in our core markets.
  • We have a proven business model with strong year-on-year revenue and margin growth.

Share Price

11.00p Change: 0.00p at 16:00 on 12/3/10

Detailed Share Price Figures

Latest Announcements

Information on this page is updated via a feed from the London Stock Exchange's Regulatory News Service.

More Regulatory News Announcements



15 minute delayed prices from the London Stock Exchange provided by Hemscott Group Limited.
© 2010 PuriCore plc. Terms & Conditions. Privacy Policy. Site Map.
Home | About PuriCore | Our Technology | Endoscopy | Food Safety | Wound Care | Laboratory